Mrv0541 07221312512D 10 10 0 0 0 0 999 V2000 -0.9723 0.7661 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.6868 0.3536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6868 -0.4714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9723 -0.8839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.2579 -0.4714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2579 0.3536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9723 -1.7089 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.2579 -2.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2579 -2.9464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4566 -3.3589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 1 6 1 0 0 0 0 4 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 M END > DBMET00920 > drugbank > OCCON1CCOCC1 > InChI=1S/C6H13NO3/c8-3-6-10-7-1-4-9-5-2-7/h8H,1-6H2 > WTPGFRPRHSDKNE-UHFFFAOYSA-N > C6H13NO3 > 147.1723 > 147.089543287 > 4 > 23 > 1.8029054057990754e-07 > 15.363017465017174 > 1 > 1 > 0 > 0 > 2-(morpholin-4-yloxy)ethan-1-ol > -0.66 > -1.1053679706666673 > 0.78 > 0 > 0 > 1 > 0 > 15.05196133872306 > 0.2767270829934352 > 41.93000000000001 > 36.3071 > 3 > 1 > 8.83e+02 g/l > biotin > 0 > DBMET00920 > N-(2-hydroxyethyl)-morpholine N-oxide $$$$